Street Calls of the Week
DUBLIN - Cardinal Health (NYSE:CAH), a $36.7 billion healthcare distribution giant with over $222 billion in annual revenue, announced Tuesday plans to build a new flagship forward distribution center in Indianapolis, Indiana as part of its strategy to expand and modernize its pharmaceutical distribution network. According to InvestingPro data, the company maintains strong financial health with consistently low price volatility.
The 230,000-square-foot facility will feature advanced automation technology, including what the company describes as an "industry-first robotic storage and retrieval system" developed in partnership with warehouse automation provider Swisslog.
According to the company’s press release, the new center will support Cardinal Health’s distribution of more than 70,000 pharmaceutical and specialty deliveries daily across the United States. The facility will incorporate real-time inventory visibility systems and automated order fulfillment processes.
"We’re continuing to make strategic investments in our core distribution network to drive service, enhance efficiency and meet the evolving needs of our customers with even greater reliability and responsiveness," said Debbie Weitzman, CEO of Pharmaceutical & Specialty Solutions at Cardinal Health.
The Indianapolis facility represents the second pharmaceutical distribution center the company has announced since 2024. It is expected to be fully operational by fall 2027 and will create more than 100 new jobs in Indiana.
Jamie Barker, SVP of Pharmaceutical & Specialty Supply Chain Operations, stated that the automation technology will work alongside Cardinal Health employees to improve operational efficiencies and enhance both employee and customer experiences.
Cardinal Health is a distributor of pharmaceuticals and specialty products that also operates nuclear pharmacies and manufacturing facilities. The company’s robust financial position is highlighted by its ability to cover interest payments through cash flows, as revealed in InvestingPro’s comprehensive analysis, which includes 12 additional key insights available to subscribers.
In other recent news, Cardinal Health reported its fourth-quarter earnings for fiscal 2025, which showed a slight earnings beat but missed revenue forecasts. The company posted earnings per share of $2.08, surpassing the expected $2.03, while revenue was $60.2 billion, falling short of the forecasted $60.92 billion. Additionally, Cardinal Health completed a $1 billion notes offering to fund its proposed acquisition of Solaris Health. This offering includes $600 million of 4.500% notes due in 2030 and $400 million of 5.150% notes due in 2035. The funds will be used for the acquisition and related expenses, with any remaining funds available for general corporate purposes. Furthermore, Cardinal Health’s Board of Directors approved a quarterly dividend of $0.5107 per share, to be paid from the company’s capital surplus. Shareholders of record as of October 1, 2025, will receive the payment on October 15, 2025.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.